SHM collaborates with the Academic Medical Center (AMC) of the University of Amsterdam (UvA) on various projects. Led by Prof. Peter Reiss (Department of Global Health (a subdivision of the Department of Infectious Diseases), AMC, Amsterdam, and director of SHM), the Co-morbidity and Aging with HIV (AGEhIV) cohort study aims to assess the incidence and prevalence of a broad range of co-morbidities and known risk factors for these co-morbidities in HIV-infected patients compared with non-HIV-infected individuals. Another collaboration closely associated with the AGEhIV cohort study, is the COBRA (Co-morbidity in relation to AIDS) programme, which aims to further investigate these issues in collaboration with a number of European partners, for example by identifying reliable biomarkers of co-morbidity and ageing in the context of HIV (refer to http://fp7-cobra.eu for further information). As a COBRA partner, SHM collaborates with the AMC and provides the data collection infrastructure for monitoring the incidence and prevalence of a number of these co-morbidities. The results obtained from this research may be used to inform and adapt national and international guidelines for prevention and management of co-morbidities in ageing HIV-infected individuals.
SHM also makes a contribution in terms of expertise in methodology and data management to the HIV Transmission Elimination Amsterdam (H-Team) project, led by the Amsterdam Institute for Global Health and Development and the department of Global Health at the AMC. The project is a multidisciplinary and interdisciplinary collaboration involving various stakeholders from preventative and curative HIV care and from other target groups (including Public Health Service Amsterdam (Geneeskundige en Gezondheidsdienst Amsterdam; GGD Amsterdam), SOA Aids Nederland, Dutch HIV Association (HIV vereniging Nederland), Amsterdam hospitals, Maasstad Ziekenhuis in Rotterdam, Leids Universitair Medisch Centrum, Erasmus MC, and the National Institute for Public Health and the Environment) that aims to reduce the number of new HIV infections in Amsterdam.